Medicinal Organic Cannabis Australia (MOCA) has entered into a partnership with Sementi, one of Europe’s largest livestock feed producers, to manufacture a range of medical cannabis-based feed supplements for high-value livestock.
The new product range will include a cannabinoid formula developed by MOCA and sold under the MOCA CBD brand and will enter the market for distribution in December 2020.
MOCA co-founder and managing director Alessandro Sorbello said: “Cannabis medication for humans is growing rapidly around the world and we are proud to be at the forefront. We are at the very beginning of CBD for animals and are proud to be pioneering with an industry leader into this new sector that is destined to grow to over US$200 billion.”
MOCA is currently raising money from the general public to fund the expansion of its product range and import affordable organic cannabis medicine for the Australian market. The equity crowd share campaign is live until October 21 or when fully subscribed.
MOCA believes that the animal and pet market is set to grow exponentially as the health benefits become more known and promoted.
Sorbello added: “Partnering with Sementi makes us extremely well positioned to become market leaders in this new cannabis-based nutraceutical product designed for high-value animals throughout Europe.”